Pegfilgrastim promotes neutrophil recovery in elderly breast cancer patients following anthracycline-containing chemotherapy

被引：0
|
作者：
Brugger, W.
Bacon, P.
Lawrinson, S.
Romieu, G.
机构：
[1] Univ Freiburg, Schwarzwald Baar Clin, Villingen Schwenningen, Germany
[2] Amgen Europe GmbH, Zug, Switzerland
[3] Amgen Ltd, Uxbridge, Middx, England
[4] CRLC Val Aurelle, Montpellier, France
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [21] Tumour infiltrating lymphocyte (TIL) and chemokine gene signature predicts for benefit of anthracycline-containing chemotherapy in breast cancer patients
    Braunstein, M.
    Yao, C.
    Lyttle, N.
    Liao, L.
    Boutros, P. C.
    Twelves, C. J.
    Bartlett, J. M. S.
    Spears, M.
    CANCER RESEARCH, 2016, 76
  • [22] HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients
    L Del Mastro
    P Bruzzi
    G Nicolò
    G Cavazzini
    A Contu
    M D'Amico
    A Lavarello
    F Testore
    B Castagneto
    E Aitini
    L Perdelli
    C Bighin
    R Rosso
    Marco Venturini
    British Journal of Cancer, 2005, 93 : 7 - 14
  • [23] Early acute HELLP-Syndrome due to anthracycline-containing adjuvant Chemotherapy for Patients with Breast Cancer: A Case Report
    Lindemann, T.
    Gal, M.
    Rupp, N.
    Krauss, T.
    Kratschmar, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E255 - E255
  • [24] Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy
    Kan Yonemori
    Noriyuki Katsumata
    Masayuki Kaneko
    Hajime Uno
    Koji Matsumoto
    Tsutomu Kouno
    Chikako Shimizu
    Masashi Ando
    Masahiro Takeuchi
    Yasuhiro Fujiwara
    Breast Cancer Research and Treatment, 2007, 103 : 313 - 318
  • [25] HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients
    Del Mastro, L
    Bruzzi, P
    Nicolò, G
    Cavazzini, G
    Contu, A
    D'Amico, M
    Lavarello, A
    Testore, F
    Castagneto, B
    Aitini, E
    Perdelli, L
    Bighin, C
    Rosso, R
    Venturini, M
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 7 - 14
  • [26] Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy
    Yonemori, Kan
    Katsumata, Noriyuki
    Kaneko, Masayuki
    Uno, Hajime
    Matsumoto, Koji
    Kouno, Tsutomu
    Shimizu, Chikako
    Ando, Masashi
    Takeuchi, Masahiro
    Fujiwara, Yasuhiro
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (03) : 313 - 318
  • [27] Effect of olanzapine for breast cancer patients resistant to triplet antiemetic therapy with nausea due to anthracycline-containing adjuvant chemotherapy
    Sato, Junya
    Kashiwaba, Masahiro
    Komatsu, Hideaki
    Ishida, Kazushige
    Nihei, Satoru
    Kudo, Kenzo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (05) : 415 - 420
  • [28] p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens
    Bottini, A
    Dogliotti, L
    Bersiga, A
    Brizzi, MP
    Berruti, A
    ANNALS OF ONCOLOGY, 2003, 14 (07) : 1156 - 1156
  • [29] Anthracycline-containing adjuvant chemotherapy does not predict worse quality of life (QL) in operated breast cancer patients (BCP).
    Mihaylova, Z
    Antonov, R
    Dudov, A
    ANNALS OF ONCOLOGY, 2000, 11 : 17 - 17
  • [30] Trastuzumab before breast surgery: is concurrent administration with anthracycline-containing chemotherapy necessary?
    Del Mastro, L.
    Bighin, C.
    Bini, G.
    Giraudi, S.
    Taveggia, P.
    Levaggi, A.
    Canavese, G.
    Rescinito, G.
    Pronzato, P.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1376 - U274
12345